The Molecular Diagnostics in Infectious Disease Testing market was valued at US$ xx in 2023. The market for Molecular Diagnostics in Infectious Disease Testing is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. The report offers detailed coverage of Molecular Diagnostics in Infectious Disease Testing industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Molecular Diagnostics in Infectious Disease Testing by geography. The report splits the market size, by volume and value, on the basis of application type and geography. In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Molecular Diagnostics in Infectious Disease Testing market are discussed. The market is segmented by types: Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) Microarrays Next-Generation Sequencing (NGS) Hybridization Others It can be also divided by applications: Hospitals Clinics Academic Institutes Laboratories Others And this report covers the historical situation, present status and the future prospects of the global Molecular Diagnostics in Infectious Disease Testing market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America. Finally, the report provides detailed profile and data information analysis of leading company. Abbott BD BioMerieux Thermo Fisher Scientific Roche Siemens Veridex Luminex GenMark Diagnostics Qiagen Genomix Biotech BioTheranostics Report Includes: - xx data tables and xx additional tables - An overview of global Molecular Diagnostics in Infectious Disease Testing market - An detailed key players analysis across regions - Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031 - Insights into regulatory and environmental developments - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Molecular Diagnostics in Infectious Disease Testing market - Profiles of major players in the industry, including Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche..... Research objectives To study and analyze the global Molecular Diagnostics in Infectious Disease Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031. To understand the structure of Molecular Diagnostics in Infectious Disease Testing market by identifying its various subsegments. Focuses on the key global Molecular Diagnostics in Infectious Disease Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years. To analyze the Molecular Diagnostics in Infectious Disease Testing with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Molecular Diagnostics in Infectious Disease Testing submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents Global Molecular Diagnostics in Infectious Disease Testing Market Report 2024, Forecast to 2031 1 Scope of the Study 1.1 Molecular Diagnostics in Infectious Disease Testing Introduction 1.2 Research Programs 1.3 Analysis of Macroeconomic Indicators 1.4 Years Considered 1.5 Methodology 1.6 Data Source 1.7 Research Objectives 2 Molecular Diagnostics in Infectious Disease Testing Industry Overview 2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size (Million USD) Comparison by Regions (2024-2031) 2.1.1 Molecular Diagnostics in Infectious Disease Testing Global Main Region Market Analysis 2.2 Market Analysis by Type 2.2.1 Polymerase Chain Reaction (PCR) 2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) 2.2.3 Microarrays 2.2.4 Next-Generation Sequencing (NGS) 2.2.5 Hybridization 2.2.6 Others 2.3 Market Analysis by Application 2.3.1 Hospitals 2.3.2 Clinics 2.3.3 Academic Institutes 2.3.4 Laboratories 2.3.5 Others 2.4 Global Molecular Diagnostics in Infectious Disease Testing Revenue, Sales and Market Share by Manufacturer 2.4.1 Global Molecular Diagnostics in Infectious Disease Testing Sales and Market Share by Manufacturer (2019-2023) 2.4.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Manufacturer (2019-2023) 2.4.3 Global Molecular Diagnostics in Infectious Disease Testing Industry Concentration Ratio (CR5 and HHI) 2.4.4 Top 5 Molecular Diagnostics in Infectious Disease Testing Manufacturer Market Share 2.4.5 Top 10 Molecular Diagnostics in Infectious Disease Testing Manufacturer Market Share 2.4.6 Date of Key Manufacturers Enter into Molecular Diagnostics in Infectious Disease Testing Market 2.4.7 Key Manufacturers Molecular Diagnostics in Infectious Disease Testing Product Offered 2.4.8 Mergers & Acquisitions Planning 2.5 Molecular Diagnostics in Infectious Disease Testing Historical Development Overview 2.6 Market Dynamics 2.6.1 Market Opportunities 2.6.2 Market Risk 2.6.3 Market Driving Force 2.6.4 Porter's Five Forces Analysis 2.7 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostics in Infectious Disease Testing Industry Impact 2.7.1 How the Covid-19 is Affecting the Molecular Diagnostics in Infectious Disease Testing Industry 2.7.2 Molecular Diagnostics in Infectious Disease Testing Business Impact Assessment - Covid-19 2.7.3 Market Trends and Molecular Diagnostics in Infectious Disease Testing Potential Opportunities in the COVID-19 Landscape 2.7.4 Measures / Proposal against Covid-19 3 Related Market Analysis 3.1 Related Market Overview 3.2 Macro Analysis of Upstream Markets 3.3 Key Players in Related Markets 3.4 Related Markets Trend Analysis 4 Global Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Regions 4.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Regions 4.1.1 Global Molecular Diagnostics in Infectious Disease Testing Sales and Market Share by Regions (2019-2023) 4.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Regions (2019-2023) 4.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 4.3 APAC Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 4.4 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 4.5 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 4.6 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5 Europe Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Countries 5.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Countries 5.1.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2019-2023) 5.1.2 Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.1.3 UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.1.4 France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.1.5 Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.1.6 Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.1.7 Spain Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 5.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue (Value) by Manufacturers (2019-2023) 5.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 5.4 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Application (2019-2023) 6 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Countries 6.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Countries 6.1.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2019-2023) 6.1.2 China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.1.3 Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.1.4 Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.1.5 India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.1.6 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.1.7 Australia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 6.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue (Value) by Players (2019-2023) 6.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 6.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Application (2019-2023) 7 North America Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Countries 7.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Countries 7.1.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2019-2023) 7.1.2 United States Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 7.1.3 Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 7.1.4 Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 7.2 North America Molecular Diagnostics in Infectious Disease Testing Revenue (Value) by Players (2019-2023) 7.3 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 7.4 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Application (2019-2023) 8 South America Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Countries 8.1 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Countries 8.1.1 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2019-2023) 8.1.2 Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 8.2 South America Molecular Diagnostics in Infectious Disease Testing Revenue (Value) by Players (2019-2023) 8.3 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 8.4 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Application (2019-2023) 9 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Size Categorized by Countries 9.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Countries 9.1.1 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2019-2023) 9.1.2 GCC Countries Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 9.1.3 Turkey Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 9.1.4 Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 9.1.5 South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2019-2023) 9.2 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue (Value) by Players (2019-2023) 9.3 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 9.4 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Application (2019-2023) 10 Global Molecular Diagnostics in Infectious Disease Testing Market Segment by Type 10.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2019-2023) 10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2024-2031) 10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate 10.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate 10.5 Microarrays Revenue Growth Rate 10.6 Next-Generation Sequencing (NGS) Revenue Growth Rate 10.7 Hybridization Revenue Growth Rate 10.8 Others Revenue Growth Rate 11 Global Molecular Diagnostics in Infectious Disease Testing Market Segment by Application 11.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2019-2023) 11.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2024-2031) 11.3 Hospitals Revenue Growth Rate (2015-2025) 11.4 Clinics Revenue Growth Rate (2015-2025) 11.5 Academic Institutes Revenue Growth Rate (2015-2025) 11.6 Laboratories Revenue Growth Rate (2015-2025) 11.7 Others Revenue Growth Rate (2015-2025) 12 Market Forecast for Molecular Diagnostics in Infectious Disease Testing 12.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2024-2031) 12.2 Molecular Diagnostics in Infectious Disease Testing Market Forecast by Regions (2024-2031) 12.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2024-2031) 12.4 APAC Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2024-2031) 12.5 North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2024-2031) 12.6 South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2024-2031) 12.7 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2024-2031) 13 Analysis of Molecular Diagnostics in Infectious Disease Testing Industry Key Vendors 13.1 Abbott 13.1.1 Company Details 13.1.2 Product Information 13.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.1.4 Main Business Overview 13.1.5 Abbott News 13.2 BD 13.2.1 Company Details 13.2.2 Product Information 13.2.3 BD Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.2.4 Main Business Overview 13.2.5 BD News 13.3 BioMerieux 13.3.1 Company Details 13.3.2 Product Information 13.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.3.4 Main Business Overview 13.3.5 BioMerieux News 13.4 Thermo Fisher Scientific 13.4.1 Company Details 13.4.2 Product Information 13.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.4.4 Main Business Overview 13.4.5 Thermo Fisher Scientific News 13.5 Roche 13.5.1 Company Details 13.5.2 Product Information 13.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.5.4 Main Business Overview 13.5.5 Roche News 13.6 Siemens 13.6.1 Company Details 13.6.2 Product Information 13.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.6.4 Main Business Overview 13.6.5 Siemens News 13.7 Veridex 13.7.1 Company Details 13.7.2 Product Information 13.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.7.4 Main Business Overview 13.7.5 Veridex News 13.8 Luminex 13.8.1 Company Details 13.8.2 Product Information 13.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.8.4 Main Business Overview 13.8.5 Luminex News 13.9 GenMark Diagnostics 13.9.1 Company Details 13.9.2 Product Information 13.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.9.4 Main Business Overview 13.9.5 GenMark Diagnostics News 13.10 Qiagen 13.10.1 Company Details 13.10.2 Product Information 13.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.10.4 Main Business Overview 13.10.5 Qiagen News 13.11 Genomix Biotech 13.11.1 Company Details 13.11.2 Product Information 13.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.11.4 Main Business Overview 13.11.5 Genomix Biotech News 13.12 BioTheranostics 13.12.1 Company Details 13.12.2 Product Information 13.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue and Gross Margin (2019-2023) 13.12.4 Main Business Overview 13.12.5 BioTheranostics News 14 Research Findings and Conclusion 15 Appendix